Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)

SHE:000590 Revenue

Guhan Pharmaceutical Group had revenue of 71.67M CNY in the quarter ending March 31, 2026, with 9.89% growth. This brings the company's revenue in the last twelve months to 344.12M, up 3.86% year-over-year. In the year 2025, Guhan Pharmaceutical Group had annual revenue of 337.67M, down -1.61%.

• Revenue (ttm): 344.12M
• Revenue Growth: +3.86%
• P/S Ratio: 7.72
• Revenue / Employee: 323.42K
• Employees: 1,064
• Market Cap: 2.66B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	337.67M	-5.53M	-1.61%
Dec 31, 2024	343.21M	-61.44M	-15.18%
Dec 31, 2023	404.65M	54.12M	15.44%
Jan 1, 2023	350.53M	49.75M	16.54%
Jan 1, 2022	300.77M	25.68M	9.34%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error